TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
IFRX

InflaRx N.V.

Healthcare · Biotechnology

1.80$ -3.7% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

InflaRx N.V. (IFRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 55 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IFRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
3.6 30 124 159 122 88 125 102 120 76 55
3.5 29 124 158 119 86 96 97 109 72 54
3.3 29 123 55 33 26 26 16 13 18 16
3.3 29 123 157 115 81 83 82 13 18 46
0.1 0.2 0.1 – 1.1 1.4 1.3 1.4 3.8 1.7 1.4
0.0 0.0 0.5 0.0 – – – 0.0 11 6.9 0.0
0.1 0.1 0.2 0.6 1.4 1.0 1.7 – – – –
0.0 0.0 0.0 0.0 – – – – – – –
0.0 0.0 0.0 0.2 0.5 0.4 0.2 0.1 0.0 0.0 0.0
21 55 4.8 7.8 14 10 20 14 18 15 14
0.4 1.7 4.8 7.8 14 10 19 13 17 14 13
0.0 0.0 0.3 0.0 0.5 0.3 0.4 0.4 0.4 0.4 0.3
0.4 1.5 4.5 6.7 12 1.7 1.7 5.0 5.1 3.4 5.4
21 53 0.0 0.0 – – – – – – –
-18 -26 119 151 107 78 105 88 103 61 42
-18 -27 -51 -81 -134 -168 -214 -243 -286 -332 -378
23 23 9.4 25 26 27 42 44 55 59 67

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?